학술논문
Development and validation of a host-dependent, PDL1-independent, biomarker to predict 6-month progression-free survival in metastatic non-small cell lung cancer (mNSCLC) patients treated with anti-PD1 immune checkpoint inhibitors (ICI) in the CERTIM Cohort: The ELY study
Document Type
Journal
Author
Boudou-Rouquette, Pascaline; Arrondeau, Jennifer; Gervais, Claire; Durand, Jean-Philippe; Fabre, Elizabeth; De Percin, Sixtine; Villeminey, Clementine Vaquin; Piketty, Anne-Catherine; Rassy, Nathalie; Ulmann, Guillaume; Damotte, Diane; Mansuet-Lupo, Audrey; Giraud, Frederique; Alifano, Marco; Wislez, Marie; Alexandre, Jerome; Jouinot, Anne; Goldwasser, Francois
Source
Subject
Language
English
ISSN
23523964